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Abstract
OBJECTIVE: To observe the impact of Shijueming
(Concha Haliotidis) on spontaneously hypertensive
rats via blood pressure, serum calcium, vascular
smooth muscle membrane L-type calcium channel
α1 C subunit (CaL-α1C), plasma membrane calci-
um-ATPase (PMCA) mRNA expression, and the
L-type calcium channel in vascular smooth muscle
cells.
METHODS: Twelve-week-old male rats with sponta-
neous hypertension were divided into three
groups: a Shijueming (Concha Haliotidis) group
(group 1), a nifedipine group (group 2), and a dis-
tilled water group (group 3). All were given a
four-week treatment. Blood pressure and dissocia-
tive serum calcium were examined before treat-
ment. Blood pressure was taken every week during
treatment. Atomic absorption spectrometry was
used to examine dissociative serum calcium. Re-
verse transcription-polymerase chain reaction was
used to examine the expression of CaL-α1C and PM-
CA1 mRNA. The patch clamp technique was used
to examine the electrophysiological characteristics
of the vascular smooth muscle cell calcium chan-
nels.
RESULTS: After treatment, blood pressure of the
Shijueming (Concha Haliotidis) group lowered but
not significantly (P>0.05). Blood pressure of the
nifedipine group lowered significantly (P<0.05).
Blood pressure of the distilled water group re-
mained high. The concentration of serum calcium
in the Shijueming (Concha Haliotidis) and the dis-
tilled water groups lowered (P<0.05). Expression of
CaL-α1C mRNA in the nifedipine group decreased
compared with the distilled water group (P<0.01).
There was the decreasing trend in the Shijueming
(Concha Haliotidis) group, but it was not statistically
significant. Shijueming (Concha Haliotidis) also had
effects on the expression of PMCA1 mRNA but with-
out statistical significance. However, there was a
significant decreasing effect on vascular smooth
muscle cell ICa-L flow.
CONCLUSION: This study indicated that Shijuem-
ing (Concha Haliotidis) could increase serum calci-
um and decrease blood pressure. It may work by in-
fluencing calcium channels, expression of PMCA1
mRNA, and regulating ion calcium channels and
calcium-ATPase.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Ca2+ plays a central role in a number of important phys-
iological processes determining vascular smooth muscle
function and hypertension.1-4 In hypertension patients,
the concentration of serum calcium is low. This sug-
gests that Shijueming (Concha Haliotidis) could lower
blood pressure. However, the epidemiological literature
suggests that the calcium and potassium content of the
diet have a negative correlation with the blood pres-
sure.5
Clinical studies have also shown that calcium supple-
mentation has a minimal effect on lowering blood pres-
sure.6,7 A meta-analysis of over 4500 patients showed
an average of 1.4 mm Hg reduction in the systolic
blood pressure with calcium supplementation.8 All anal-
yses indicated that calcium and magnesium supple-
ments were unlikely to lower blood pressure in adults
with high-normal diastolic blood pressure. Subgroup
analyses, used to formulate hypotheses, raise the possi-
bility of a benefit to white women, which requires test-
ing in future trials.9 Long-term dietary cholecalcifer-
ol-calcium supplementation reduces the odds of falling
in ambulatory older women by 46%, and in less active
women by 65%. Supplementation had effects in men
independent of their physical activity level.10 Calcium
supplementation of 1 g/day does not produce biologi-
cally significant effects on body weight. Moreover, its
hypotensive effect is small and transient in women.11
Overall, the decline in blood pressure is so small that
the clinical benefit is limited.
Shijueming (Concha Haliotidis) is the pharmaceutical
name for abalone shell which is composed of CaCO3,
it is commonly used in Traditional Chinese Medicine.
We studied whether oral Shijueming (Concha Hali-
otidis) use has any effect on hypertension and its mech-
anism in spontaneously hypertensive rats.
METHODS
Experiment and procedures
Spontaneously hypertensive rats (SHR) (12 weeks old),
were divided into three groups: group 1, Shijueming
(Concha Haliotidis) (1.6 mg/mL); group 2, nifedipine
(2.0 mg/mL); and group 3, distilled water. Rats were
intragastrically administered drugs at a dose of 1 mL/
100 g once a day for four weeks. All animal studies
were approved by our institutional committee for the
care and use of animals in research and education.
Blood pressure measurement
Systolic blood pressure was examined before treatment.
During and after treatment, blood pressure was taken
weekly.
Detection of calcium in the serum
Before and after treatment, 1.0 mL of blood was taken
from SHR, and 100 μL serum was separated and
stored at −20℃ until calcium determination.
Calcium channel measurement
Selected cells were placed under a microscope and the
electrode was filled. Water was poured at a positive
pressure (R: 2-5 MΩ) to establish an electrical poten-
tial. The electrode was gently pressed on the cell to dis-
tort minimally and establish high resistance (R>1 GΩ)
with c-fast compensation. The membrane was broken
by impulse negative pressure or electroshock. Capaci-
tance was recorded, compensated with c-slow and c-se-
ries, parameters were recorded, and the ion flow pic-
ture was saved.
mRNA detection
There are 4 isomers for the plasma membrane calci-
um-ATPase (PMCA): PMCA1, PMCA2, PMCA3,
PMCA4. The main isomer expressed in smooth muscle
cells is PMCA1.12 Therefore, we measured the expres-
sion of PMCA1. We took the pars abdominalis aortae
and froze it in liquid nitrogen. We used a TOYO-
BO-RT-PCR kit (Toyobo, Osaka, Japan). PMCA1
PCR production was amplified to 250 bp. The primers
were: forward 5′-GAAATCGCAGCCATAGTATC-3′ ,
and reverse 5′-CTGATGACGGTGAACTTCTG-3′ .
CaL-α1C PCR production was amplified to 271 bp.
The primers were: forward 5′-AGTGATTGCCTACG-
GACTAC-3′ and reverse 5′-TTGATGATG-
GAGTTCAGGAC-3′ . β-actin PCR production was
amplified to 298 bp. The primers were: forward 5′-AT-
GTTTGAGACCTTCAACAC-3′ and reverse
5′-GGCCATCTCTTGCTCGAAGTC-3′ . The condi-
tions for total RNA extraction were: 37℃ for 60 min,
95℃ for 10 min, and 4℃ for 5 min. CaL-α1C PCR
conditions were: 95℃ for 4 min, 94℃ for 30 s, 55℃
for 30 s, 72℃ for 30 s, recycle 35 times, 72℃ for 4 min,
and pause at 4℃. PMCA1 PCR conditions were: 95℃
for 4 min, 94℃ for 30 s, 58℃ for 30 s, 72℃ for 30 s,
recycle 35 times, 72℃ for 4min, and pause at 4℃.
Kodak Digital Science 1D Image Analysis Software Ver-
sion 2.0.3 (Eastman Kodak, Rochester, NY, USA) and
SPSS 16.0 (SPSS Inc., Chicago, IL, USA) were used to
analyze data. A t-test was used for in-group compari-
son and mono-factor analysis was used for be-
tween-group comparison. Data were presented as mean±
standard deviation ( xˉ±s).P<0.05was regarded as a signif-
icant difference.
RESULTS
Effect of Shijueming (Concha Haliotidis) on blood
pressure
After 4 weeks of drug intervention, the blood pressure
of groups 1 and 3 had a decreasing trend compared
with prior treatment. The decrease had no statistical
significance (P>0.05). Systolic pressure in group 2 de-
creased significantly (P<0.05) (Figure 1).
After drug intervention, the serum calcium concentra-
tion in group 1 (P<0.05), and group 3 decreased signifi-
cantly (P<0.01). Compared to group 3 (distilled water),
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group 2 was much higher (P<0.05), and group 1 had no
statistical difference with group 3 (P>0.05)(Figure 2).
Effects on calcium channels
At the same level of pressure, the Shijueming (Concha
Haliotidis) group I-V curve moved higher. The peak
value of Shijueming (Concha Haliotidis) was lower than
that of the control group , indicating that Shijueming
(Concha Haliotidis) decreased the trend of ICa-L, and
blocked the vascular smooth muscle L-type calcium
channel. However, the difference in trends was not sta-
tistically significant (Figure 3).
As shown in Figure 4, the control group had a maxi-
mum of −10 mV, and Shijueming (Concha Haliotidis)
group had a maximum of −25 mV.
Expression of mRNA
The mRNA expression results showed that nifedipine
could down-regulate the expression of CaL-α1C
mRNA in SHR (P<0.05). Shijueming (Concha Hali-
otidis) could also down-regulate expression of CaL-α
1C mRNA in SHR (P>0.05). And it was statistical sig-
nificance (P<0.05) in the expression of CaL-α1C
mRNA levels between Concha Haliotidis and nifedip-
ine (Figure 5, 6). Results also showed that Shijueming
(Concha Haliotidis) enhanced the expression level of
PMCA mRNA in SHR with no statistical significance
(P>0.05, Figure 7).
Comparison of calcium channel α1 C mRNA
expression among three groups
Nifedipine downregulated the expression of CaL-α1C
mRNA in SHR (P<0.05). Shijueming (Concha Hali-
otidis) also downregulated expression of CaL-α1C
mRNA in SHR, but not significantly (P>0.05). There
was statistical significance (P<0.05) in the difference of
CaL-α1C expression between Concha Haliotidis and
nifedipine. Expression of CaL-α1C mRNA in the nife-
dipine group was lower than that of the distilled water
group (P<0.05), but there was no statistical difference
between them (Figure 7).
Figure 8 shows that Shijueming (Concha Haliotidis) en-
hanced the expression of PMCA mRNA in SHR, but
there not significantly.
DISCUSSION
Shijueming (Concha Haliotidis) is suggested to lower
blood pressure by various mechanisms. A high calcium
diet may attenuate genetic hypertension by inducing
an osmotic diuresis.13 Under normal conditions, the
concentration of calcium in cells is 20 000 times lower
than outside of cells.14 There are three types of pres-
sure-dependent calcium channels in vascular smooth
muscle cells, namely L, T, and R. L-type channels,
which are under calcium control, are the main chan-
nels for calcium inflow to induce vascular smooth mus-
cle relaxation-contraction activity. It has been reported
that higher calcium concentrations can strengthen the
polarization of the vascular smooth muscle cytomem-
brane and relax muscle. This is called the mem-
brane-stabilizing action of calcium.15 Calcium is a key
signaling molecule in determining the tension of vascu-
lar smooth muscle and the reactiveness of blood ves-
sels. Many factors that affect blood pressure are related
to calcium control. The L-type pressure-dependent cal-
cium channel and the Ca2+-ATPase on the cytoplasmic
membrane are crucial to keeping calcium in balance.
We found that, as rats aged and as the concentration of
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Figure 1 Comparison of blood pressure in three different
groups after treatment
Group 1: Shijueming (Concha Haliotidis) group; group 2: nife-
dipine group; group 3: distilled water group.
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Figure 2 Comparison of serum calcium concentration
among three groups
Group 1: Shijueming (Concha Haliotidis) group; group 2: nife-
dipine group; group 3: distilled water group.
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Figure 4 Voltage dependent current of ventricular myocytes
A: control group; B: Shijueming (Concha Haliotidis) group
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serum calcium in SHR decreased, blood pressure rose
obviously. After the intervention of Shijueming (Concha
Haliotidis), serum calcium rose, and blood pressure had
declined.However, neither had statistical significance.
After a 4-week treatment, the calcium concentration in
the nifedipine group had no significant decline, which
is consistent with the literature.16 The serum from the
nifedipine group can decrease inflow of vascular
smooth muscle cell ICa-L, and depress vascular smooth
muscle cell ICa-L. This indicates that nifedipine has an
evident inhibiting effect on L-type calcium channels.17
After a 4-week treatment, serum calcium in the Shi-
jueming (Concha Haliotidis) group was lower, indicat-
ing that Shijueming (Concha Haliotidis) could block
the inflow of vascular smooth muscle cell ICa-L. High
calcium levels blocking L-type calcium channels could
explain the mechanism of Shijueming (Concha Hali-
otidis) in decreasing the peak value of vascular smooth
muscle ICa-L.
During hypertension, the transportation, application,
and metabolism of calcium are abnormal. As current of
the L-type calcium channel increases, the opening of
the channel is faster and inactivity is slower. This
makes the opening of the channel longer and sensitive
to calcium so expression is not lowered. Negative feed-
back control of calcium is therefore weakened.18 Shi-
jueming (Concha Haliotidis) can depress expression of
CaL-α1C mRNA, decrease calcium inflow, up-regulate
expression of PMCA1 mRNA, and improve calcium
overloading in smooth muscle cells during hyperten-
sion to expand vessels and decrease blood pressure.
In conclusion, this study showed that, through use of
Shijueming (Concha Haliotidis), serum calcium in-
creased and blood pressure declined. It may work by in-
fluencing expression of PMCA1 mRNA and regulating
ion calcium channels and calcium-ATPase.
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